OISTV

Watch presentations from innovators/entrepreneurs, surgeons, academia, venture capitalists, industry leaders and private & public companies.


Dorit Donoviel on Space & Ophthalmology

Visual Disorders In Space And How Ophthalmology Can Help

Jeff George Q&A at OIS@AAO

Jeff George’s Vision for Innovation at Alcon

Laurent Attias Q&A at OIS@AAO

Laurent Attias Explains How Alcon Will Maximize the Ora System’s Potential

Tom Frinzi Q&A at OIS@AAO

WaveTec CEO Tom Frinzi Hints at Plans for Future

Tom Salemi - Jeff George Newscast

Alcon’s George Stresses Innovation

Tom Salemi Google Newscast

Google Eyes Ophthalmology

Tom Salemi IPO Newscast

CEOs Share Lessons from IPOs

Tom Salemi M&A Newscast

How to Do M&A Well

Michael Brownell Q&A at OIS@AAO

Q&A with Michael Brownell

Richard Lindstrom Q&A at OIS@AAO

Q&A with Richard Lindstrom

Jeffery Hoffman on The Ophthalmology Market

The Ophthalmology Market – A View Of The Public Sector & Exit Trends

Reinventing Your Company - Panel Discussion

Second Acts – Reinventing Your Company

Jonathan Norris on Private Funding Trends in Healthcare

Private Funding Trends In Healthcare

A Veiw from the NEI with Matthew McMahon

A View From The NEI – Ophthalmic Innovation in 2014

David W. Parke - View from the AAO

A View From The AAO – Ophthalmic Innovation in 2014

2014 OIS Award AGTC Founders

2014 OIS Innovator Award Presentation

FDA Q&A - Malvina & Wiley

FDA Q&A

Doug Foster of DigiSight

DigiSight

Tom Brogan of Vestrum Health

Vestrum Health

Harvey Fishman of AppVisit

AppVisit

Noel Alpins of Assort

Assort

Michael Brownell of Gobiquity

Gobiquity

CheckedUp

CheckedUp

Jeroen Cammeraat of i-Optics

i-Optics

Tom Frinzi of WaveTec Vision Systems

WaveTec Vision Systems

Tim Willis of TearScience

TearScience

Barry Cheskin of PowerVision

PowerVision

Quinton Oswald of Neurotech

Neurotech

Robert Butchofsky of Mati Therapeutics

Mati Therapeutics

Ronen Castro of IOPtima

IOPtima

Max Ostermeier of Implandata Ophthalmic Products GmbH

Implandata Ophthalmic Products GmbH

John Maroney of ForSight VISION5

ForSight VISION5

David Muller of Avedro

Avedro

Russell Trenary of InnFocus

InnFocus

Dan Myers of Alimera Sciences

Alimera Sciences

Franz Obermayr of Panoptes

Panoptes Developing Inhibitor For Local Treatments In Ocular Disease

Shelly Boyd of Translatum Medicus

Translatum Medicus Developing Option To Treat Dry AMD

Charlie McDermott of Kala Pharmaceuticals

Kala Pharmaceuticals Offers Glimpse Into Preclinical Pipeline

John Freshly of ONL

ONL Therapeutics Develops Novel Mechanism To Attack Fas Receptor Apoptosis

Vicente Anido of Aerie Pharaceuticals

Aerie Pharmaceuticals With Two ROCK Inhibitors In Development

Henry Hsu of Allysta

Allysta Pharmaceuticals Developing Multi-Kinase Inhibitor To Treat Glaucoma

Amarpreet Sawhney of Ocular Therapeutix

Ocular Therapeutix

Michael O'Rourke of GrayBug

GrayBug With Preclinical Work On Microparticle Anti-VEGF Compound GB-102

Ed Timm of Mobius Therapeutics

Mobius Therapeutics Investigates Extending Mitosol Platform

Bernhard Gunther of Novaliq

Novaliq GmbH Using Semifluorinated Alkanes To Improve Solubility Of Topical Agents

Paul Rubin of Xoma

Monoclonal Antibody Company XOMA Corp. Shares New Strategy

David R. Guyer of Ophthotech

Ophthotech Shares Late-Stage Progress of Fovista

Vicken Karageozian of Allegro

Allegro Gives Phase II News on Luminate

Page 1 of 512345